Andrea Minervini
University of Turin
Internal medicineRadiologyUrologySurgeryPathologyOncologyRenal functionEnucleationProspective cohort studyCystectomyRenal cell carcinomaProstate cancerNephrectomyBladder cancerNephron sparing surgeryIn patientPerioperativeGeneral surgeryMedicineCohort
741Publications
41H-index
4,611Citations
Publications 773
Newest
#1Antonio Andrea Grosso (UniFI: University of Florence)H-Index: 6
#2Fabrizio Di Maida (UniFI: University of Florence)H-Index: 9
Last. Andrea Minervini (UniFI: University of Florence)H-Index: 41
view all 6 authors...
Source
#1Riccardo Campi (UniFI: University of Florence)H-Index: 19
#2Riccardo Tellini (UniFI: University of Florence)H-Index: 10
Last. Andrea Minervini (UniFI: University of Florence)H-Index: 41
view all 10 authors...
Abstract null null In response to the COVID-19 pandemic, the European Association of Urology (EAU) Guidelines Office Rapid Reaction Group (GORRG) defined priority groups to guide the prioritization of surgery for nonmetastatic renal cell carcinoma (RCC). In this study we explored the diversity and predictors of histopathological findings across the EAU GORRG priority groups using a large database of 1734 consecutive patients undergoing elective surgery for nonmetastatic renal masses between 2017...
Source
#1Luca LambertiniH-Index: 2
#2Fabrizio Di MaidaH-Index: 9
Last. Giacomo Maria PirolaH-Index: 11
view all 16 authors...
Background: Phytotherapeutic agents aroused an increasing interest either as alternative or in addition to conventional therapy in the management of BPH. The aim of the article was to evaluate the clinical and functional changes after add-on treatment with Serenoa repens associated with Solanum lycopersicum, lycopene and bromelain in patients with BPH presenting with mild to moderate LUTS and previously treated only with Alfuzosin over a 6–12 months period. Materials and methods: Between January...
Source
#1Fabrizio Di Maida (UniFI: University of Florence)H-Index: 9
#2Antonio Andrea Grosso (UniFI: University of Florence)H-Index: 6
Last. Andrea Minervini (UniFI: University of Florence)H-Index: 41
view all 6 authors...
Source
#1Riccardo Campi (UniFI: University of Florence)H-Index: 19
#2Alessandro Berni (UniFI: University of Florence)H-Index: 2
Last. Tobias Klatte (Royal Bournemouth Hospital)H-Index: 34
view all 23 authors...
Background null Frailty has been recognized as a major risk factor for adverse perioperative and oncological outcomes in patients with genitourinary malignancies. Yet, the evidence supporting such an association in patients with renal cell carcinoma (RCC) is still sparse. Herein we provide an updated comprehensive overview of the impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for RCC. null Evidence acquisition null A systematic review of the ...
Source
#1Riccardo BertoloH-Index: 27
#2Pierluigi Bove (University of Rome Tor Vergata)H-Index: 22
Last. Alessandro Antonelli (University of Verona)H-Index: 27
view all 4 authors...
Source
#1Fabrizio Di Maida (UniFI: University of Florence)H-Index: 9
#2Riccardo Campi (UniFI: University of Florence)H-Index: 19
Last. Andrea Minervini (UniFI: University of Florence)H-Index: 41
view all 4 authors...
Source
#1Andrea MinerviniH-Index: 41
Last. Fabrizio Di MaidaH-Index: 9
view all 3 authors...
Source
#1Simone Albisinni (ULB: Université libre de Bruxelles)H-Index: 17
#2R. Diamand (ULB: Université libre de Bruxelles)H-Index: 8
Last. Thierry Roumeguere (ULB: Université libre de Bruxelles)H-Index: 23
view all 34 authors...
Abstract null null Objectives null To evaluate whether continuing the antiplatelet drug acetylsalicylic acid≤100mg (ASA) during Robotic-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) increases the risk of peri-and postoperative hemorrhagic complications and overall morbidity. Indeed, guidelines recommend interrupting antiplatelet therapy before radical cystectomy; however, RARC with ICUD is associated to reduced estimated blood loss and blood transfusions compare...
Source
#1Simone Sforza (UniFI: University of Florence)H-Index: 7
#2Antonio Andrea Grosso (UniFI: University of Florence)H-Index: 6
Last. Andrea Minervini (UniFI: University of Florence)H-Index: 41
view all 11 authors...
The present study aimed to assess the safety and efficacy of robot-assisted radical prostatectomy (RARP) in patients with prostate cancer (PCa) under anticoagulant (AC) and/or antiplatelet (AP) therapy, as compared to a control group, and to establish possible differences in postoperative-related morbidity. Data of all consecutive patients submitted to elective RARP for PCa from June 2017 to May 2020 at our institution were prospectively collected. Patients were divided according to the use of A...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.